Cencora director Lorence Kim resigns from board

Q: What did Cencora (COR) disclose about its Board on August 13, 2026?

Cencora disclosed that Lorence H. Kim, M.D. resigned from its Board of Directors, effective immediately after the August 13, 2026 quarterly Board meeting, and that his decision was related to external professional responsibilities.

Q: Why did Lorence H. Kim, M.D. resign from Cencora (COR)’s Board?

He resigned in connection with his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc., citing the need to devote additional time to his professional responsibilities at that company, according to Cencora’s disclosure.

Q: Was Lorence H. Kim’s resignation from Cencora (COR) due to any disagreement?

Cencora states that Dr. Kim advised his resignation was not due to any disagreement with the company on matters relating to its operations, policies, or practices, indicating it was a professional time-commitment decision.

Q: When did Lorence H. Kim’s resignation from Cencora (COR)’s Board become effective?

His resignation became effective immediately on August 13, 2026, following the conclusion of Cencora’s quarterly Board of Directors meeting held on that same date, as described in the company’s report.

Q: Which securities of Cencora (COR) are listed on the NYSE?

Cencora lists its common stock, 2.875% Senior Notes due 2028, and 3.625% Senior Notes due 2032 on the New York Stock Exchange, under the symbols COR, COR28, and COR32, respectively.

Cencora, Inc. reported that director Lorence H. Kim, M.D., resigned from its Board of Directors effective immediately on August 13, 2026, following the conclusion of the Board’s quarterly meeting.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Cencora, Inc. reported that director Lorence H. Kim, M.D., resigned from its Board of Directors effective immediately on August 13, 2026, following the conclusion of the Board’s quarterly meeting.

The company states that Dr. Kim’s decision is connected to his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc. and his need to devote additional time to those professional responsibilities. Dr. Kim advised that his resignation is not due to any disagreement regarding Cencora’s operations, policies, or practices. The company expressed appreciation for his dedicated service.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Board resignation effective date: August 13, 2026 Senior Notes coupon: 2.875% Senior Notes coupon: 3.625%

3 metrics

Board resignation effective date August 13, 2026 Effective date of Lorence H. Kim, M.D.’s resignation from the Board

Senior Notes coupon 2.875% Coupon on Senior Notes due 2028 listed on NYSE as COR28

Senior Notes coupon 3.625% Coupon on Senior Notes due 2032 listed on NYSE as COR32

Key Terms

Senior Notes, Board of Directors, Chief Financial Officer, Emerging growth company

4 terms

Senior Notes financial

"2.875% Senior Notes due 2028 | COR28 | New York Stock Exchange"

Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.

Board of Directors financial

"following the conclusion of the quarterly meeting of the Board of Directors"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

Chief Financial Officer financial

"his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc."

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

Emerging growth company regulatory

"Check the appropriate box below if the filing is intended to ... Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cencora (COR) disclose about its Board on August 13, 2026?

Cencora disclosed that Lorence H. Kim, M.D. resigned from its Board of Directors, effective immediately after the August 13, 2026 quarterly Board meeting, and that his decision was related to external professional responsibilities.

Why did Lorence H. Kim, M.D. resign from Cencora (COR)’s Board?

He resigned in connection with his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc., citing the need to devote additional time to his professional responsibilities at that company, according to Cencora’s disclosure.

Was Lorence H. Kim’s resignation from Cencora (COR) due to any disagreement?

Cencora states that Dr. Kim advised his resignation was not due to any disagreement with the company on matters relating to its operations, policies, or practices, indicating it was a professional time-commitment decision.

When did Lorence H. Kim’s resignation from Cencora (COR)’s Board become effective?

His resignation became effective immediately on August 13, 2026, following the conclusion of Cencora’s quarterly Board of Directors meeting held on that same date, as described in the company’s report.

Which securities of Cencora (COR) are listed on the NYSE?

Cencora lists its common stock, 2.875% Senior Notes due 2028, and 3.625% Senior Notes due 2032 on the New York Stock Exchange, under the symbols COR, COR28, and COR32, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/14/2026 - 04:06 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 13, 2026

Cencora, Inc.

(Exact name of registrant as specified in its charter)

Commission File Number: 1-16671

Delaware		23-3079390
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

1 West First Avenue Conshohocken PA		19428-1800
(Address of principal executive offices)		(Zip Code)

(610) 727-7000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of exchange on which registered
Common stock	COR	New York Stock Exchange (NYSE)
2.875% Senior Notes due 2028	COR28	New York Stock Exchange (NYSE)
3.625% Senior Notes due 2032	COR32	New York Stock Exchange (NYSE)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 13, 2026, following the conclusion of the quarterly meeting of the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”), Lorence H. Kim, M.D., informed the Company of his intent to resign from the Board effective immediately. Dr. Kim’s decision was made in connection with his appointment as Chief Financial Officer of Commonwealth Fusion Systems, Inc. and his need to devote additional time to his professional responsibilities at that company. Dr. Kim has advised the Company that his resignation is not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company thanks Dr. Kim for his dedicated service.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Cencora, Inc.

Date: August 14, 2026	By:	/s/ Elizabeth S. Campbell
	Name:	Elizabeth S. Campbell
	Title:	Executive Vice President and Chief Legal Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents